The type of healthcare provider administering the injections also impacts pricing
hospitalization required Maintenance of Remission: Immunomodulators (azathioprine, 6-MP, methotrexate) for steroid-dependent or frequently-relapsing disease Biologic monotherapy or combination therapy (biologic + immunomodulator) for moderate-to-severe disease Step-up or top-down approach based on disease severity, patient risk factors, and prior therapy Biologic Therapy Targets: TNF-: Infliximab (IV), adalimumab (SC), certolizumab pegol (SC) IL-12/23: Ustekinumab (IV induction, SC maintenance) Integrin: Vedolizumab (IV) IL-23: Risankizumab (IV induction, SC maintenance) JAK inhibition: Upadacitinib (oral) Surgical Management Surgery is indicated in approximately 7080% of patients with Crohns disease over their lifetime, per StatPearls
The future is bright
With retatrutide, the temptation to skip from 2mg directly to 8mg (bypassing 4mg) can trigger GI events severe enough to require medical attention
[DOI] [PubMed] [Google Scholar] 35
Wolverine Stack Dosing Protocol & Schedule Two dosing models dominate Wolverine Stack research planning
